The week in health tech, explained in plain English.Get the free newsletter →
September 23, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Finance

Oklahoma Health Campus Renamed After $150M Hamm Gift

The University of Oklahoma will rename its Oklahoma City health campus after a $150 million gift from energy executive Harold Hamm, the largest single donation in the university's history, according to a Sept. 22 news release shared with Becker's Hospital Review.

The campus is home to OU Health, the state's only academic health system. Naming an entire health campus after a single donor reflects a broader pattern in academic medicine, where major philanthropy underwrites clinical, research, and educational infrastructure that operating margins and state funding alone often cannot cover. Academic health systems face thin margins, aging facilities, and rising costs, making transformational gifts a critical funding source.

For OU Health, the money offers capital to expand capacity and research in a state that relies heavily on it for advanced and specialty care. The gift also ties one of Oklahoma's most prominent business figures directly to the future of its medical education and delivery, a relationship other academic systems increasingly cultivate to fund growth.

More in Finance

Finance

Chris Allen Named CFO of $6B UChicago Medicine

Chris Allen has been named executive vice president and CFO of the roughly $6 billion UChicago Medicine, returning to the system where he started as a budget analyst in the 1990s.

Why it matters: CFO leadership at large academic health systems is pivotal as hospitals fight to protect margins amid rising costs and heavy capital needs.

Finance

The Hidden Costs Buried in Healthcare Payment Operations

Healthcare payment costs are split across four budgets, hiding the true expense of manual and paper-based processes from finance leaders.

Why it matters: Payment operations quietly drain money that organizations cannot see because the costs are fragmented across departments.

Finance

Alkermes Orexin Agonist Shows Early Promise in ADHD

Alkermes reported that its orexin agonist showed early potential to treat ADHD, the first promise the drug class has shown for the condition.

Why it matters: A non-stimulant, novel-mechanism ADHD therapy could reshape a market long dominated by stimulants with abuse and shortage risks.